Impact of genetic polymorphisms on the sulfation of dehydroepiandrosterone and 17-β estradiol by human cytosolic sulfotransferase SULT2B1a [0.03%]
人类胞质磺基转移酶SULT2B1a催化脱氢表雄酮和雌二醇磺化的遗传多态性影响及其机制研究
Eid Alatwi,Ahsan F Bairam
Eid Alatwi
Background: Dehydroepiandrosterone (DHEA) is considered an endogenous steroid hormone precursor, and 17-ß estradiol (E2) is one of the estrogen steroid hormones. Of the 13 known human cytosolic sulfotransferases (SULTs),...
Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity: Corrigendum [0.03%]
关于CES、UGT、ABC和SLCO基因多态性与伊立替康输注反应及严重毒性的关联的勘误说明
Kelly I Nugent,Lyucheng Huang,Maisa Nazzal et al.
Kelly I Nugent et al.
Ruby Brubaker-Plitt,Chad A Bousman
Ruby Brubaker-Plitt
In Canada, access to pharmacogenetic (PGx) testing remains limited, particularly outside of research institutions, and commercial testing is often cost-prohibitive. To address access challenges, several Canadian insurance providers have beg...
Exome-wide association study identifies a phosphatidylethanolamine-binding protein 4 variant associated with idiopathic pulmonary fibrosis risk in Koreans [0.03%]
外显子组关联研究发现磷脂乙醇胺结合蛋白4的一种变异体与韩国人特发性肺纤维化风险相关
Jong-Uk Lee,Min Kyung Kim,Hun Soo Chang et al.
Jong-Uk Lee et al.
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with poor prognosis, shaped by both environmental and genetic factors. While genome-wide association studies have identified sever...
GLP1R and OCT1 variants modulate semaglutide and metformin response in type 2 diabetes [0.03%]
GLP1R和OCT1变异体通过调节司美格鲁肽和二甲双胍的药效来影响2型糖尿病患者的药物反应
Ivan Tourtourikov,Maria Kalinkova,Peter Ivanov et al.
Ivan Tourtourikov et al.
Background: Large consortia link variants in SLC22A1, SLC47A1, and GLP1R to antidiabetic response, yet few data confirm these effects in small real-world cohorts. We tested whether three common polymorphisms translate int...
Wenjian Yang,Gang Wu,Jeffery M Klco et al.
Wenjian Yang et al.
Objectives: Pharmacogenomic testing is rapidly becoming the standard of care in treating pediatric acute lymphoblastic leukemia (ALL). Risk classification of ALL can be performed through whole transcriptome sequencing (WT...
Pharmacogenomic analysis of low-density lipoprotein receptor 3' untranslated region genetic variants influencing rosuvastatin efficacy in Chinese dyslipidemia patients [0.03%]
中国高脂血症患者rosuvastatin药效的低密度脂蛋白受体3'非翻译区基因多态性药代遗传学研究
Keke Wang,Yihua Zhu,Yan Tian et al.
Keke Wang et al.
Objectives: Dyslipidemia is a crucial risk factor for atherosclerotic cardiovascular disease. Although rosuvastatin is widely used, treatment response varies significantly due to genetic variation. This study investigated...
Association of genetic variation with irinotecan infusion reactions and severe toxicity [0.03%]
基因变异与伊立替康输注反应及严重毒性的关联研究
Kelly I Nugent,Lyucheng Huang,Maisa Nazzal et al.
Kelly I Nugent et al.
Irinotecan treatment is often complicated by gastrointestinal, hematological, and infusion-related toxicities, the latter of which typically presents as acute cholinergic syndrome (ACS). While genetic variation in UGT1A1 increases toxicity ...
Annika M Czizik,Hannah Burkett,Joshua C Black et al.
Annika M Czizik et al.
It is unknown how many people in the US have had pharmacogenetic (PGx) testing and whether people want to be tested. We conducted a nationally representative survey of the general US adult population to determine the prevalence of adults th...
Microsampling with dried blood spots and mass spectrometry enables PK/PD profiling of responses to praziquantel in a Schistosoma haematobium-exposed Zimbabwean population [0.03%]
微创采样和基于质谱的药代动力学/药效学分析测定乾血斑试样的吡喹酮暴露效应关系:赞比亚斯氏血吸虫感染人群示例研究
David Twesigomwe,Grace Zdesenko,Takafira Mduluza et al.
David Twesigomwe et al.
Introduction: Praziquantel (PZQ) is commonly used to treat schistosomiasis; however, there is considerable interindividual variability in its efficacy, partly because of genetic variation. Data on this relationship is sca...